| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | carboplatin:UNC0638 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.043 | 0.4 |
| mRNA | BRD-K90370028 | CTRPv2 | pan-cancer | AAC | -0.044 | 0.4 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | TG-101348 | GDSC1000 | pan-cancer | AAC | -0.022 | 0.4 |
| mRNA | EX-527 | GDSC1000 | pan-cancer | AAC | -0.026 | 0.4 |
| mRNA | BAY 61-3606 | GDSC1000 | pan-cancer | AAC | -0.026 | 0.4 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | 0.045 | 0.4 |
| mRNA | staurosporine | CTRPv2 | pan-cancer | AAC | -0.054 | 0.4 |
| mRNA | paclitaxel | GDSC1000 | pan-cancer | AAC | -0.039 | 0.4 |